Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

Multimodality Therapy for Locally Advanced Cervical Carcinoma: State of the Art and Future Directions We reviewed the current evidence on the clinical management of these relatively rare ovarian ...

The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after first-line platinum therapies, driving demand for novel second- and later-line ...

High-risk MSCs (yellow) are more abundant in fallopian tubes from patients with STIC lesions (bottom) compared to those without these lesions (top). Researchers at the University of Pittsburgh have ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center show that combining two types of immunotherapy—engineered T cells that secrete bispecific T cell engagers (BiTEs) and ...

The current study looked at treatment data from 2 randomized trials conducted by the Women’s Health Initiative with long term follow up. The effects of MHT on incidence and mortality from ovarian ...

University of Galway have made a breakthrough in understanding the body’s response to bowel cancer, opening up new treatment possibilities for people.

With a new imaging technique, UC San Francisco scientists discover an ecosystem that determines how eggs mature and ovaries ...